NBEA

neurobeachin, the group of BEACH domain containing |WD repeat domain containing|A-kinase anchoring proteins|Armadillo like helical domain containing

Basic information

Region (hg38): 13:34942270-35673022

Links

ENSG00000172915NCBI:26960OMIM:604889HGNC:7648Uniprot:Q8NFP9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • syndromic intellectual disability (Strong), mode of inheritance: AD
  • neurodevelopmental disorder with or without early-onset generalized epilepsy (Strong), mode of inheritance: AD
  • complex neurodevelopmental disorder (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Neurodevelopmental disorder with or without early-onset generalized epilepsyADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic28554332; 30269351

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NBEA gene.

  • not provided (7 variants)
  • Neurodevelopmental disorder with or without early-onset generalized epilepsy (5 variants)
  • Inborn genetic diseases (2 variants)
  • Intellectual disability (1 variants)
  • Neurodevelopmental delay;Epilepsy (1 variants)
  • Autism spectrum disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NBEA gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
60
clinvar
6
clinvar
68
missense
5
clinvar
267
clinvar
35
clinvar
7
clinvar
314
nonsense
5
clinvar
12
clinvar
17
start loss
0
frameshift
5
clinvar
5
clinvar
2
clinvar
12
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
5
clinvar
2
clinvar
4
clinvar
11
splice region
1
8
6
2
17
non coding
1
clinvar
1
clinvar
11
clinvar
2
clinvar
2
clinvar
17
Total 16 25 287 97 15

Variants in NBEA

This is a list of pathogenic ClinVar variants found in the NBEA region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
13-34942660-C-T Abnormal bleeding;Thrombocytopenia Uncertain significance (May 01, 2020)988833
13-34942813-G-T not specified Uncertain significance (Jul 02, 2024)3339191
13-34942834-A-G Neurodevelopmental disorder with or without early-onset generalized epilepsy Uncertain significance (-)3235040
13-34942836-C-T Neurodevelopmental disorder with or without early-onset generalized epilepsy Uncertain significance (Feb 04, 2022)2434046
13-34942837-C-A Inborn genetic diseases Uncertain significance (Feb 05, 2024)3178218
13-34942840-G-A See cases Uncertain significance (Aug 19, 2021)1691037
13-34942845-G-T Uncertain significance (Oct 01, 2023)2643737
13-34942858-A-C Neurodevelopmental disorder with or without early-onset generalized epilepsy Uncertain significance (Mar 29, 2024)3065941
13-34942861-C-T NBEA-related disorder Uncertain significance (Nov 15, 2023)3031215
13-34942867-C-T Inborn genetic diseases Uncertain significance (Jan 09, 2024)3178305
13-34942868-C-G NBEA-related disorder Likely benign (Jun 01, 2024)790672
13-34942881-G-A Uncertain significance (Nov 08, 2023)3363598
13-34942893-G-A not specified Conflicting classifications of pathogenicity (Feb 06, 2024)1701220
13-34942906-GCGGGGGCAGCGGTGGTGGCGGCAC-G NBEA-related disorder Likely benign (Aug 01, 2023)2643738
13-34942915-GC-AT Neurodevelopmental disorder with or without early-onset generalized epilepsy Uncertain significance (Apr 30, 2021)2434049
13-34942922-T-G Likely benign (Aug 01, 2023)2643739
13-34942935-G-T Uncertain significance (Apr 19, 2023)2663023
13-34942936-G-A Uncertain significance (Dec 09, 2021)1691636
13-34942938-A-C Inborn genetic diseases Uncertain significance (Mar 14, 2023)2496466
13-34942938-A-G Inborn genetic diseases Likely benign (Aug 01, 2024)2523121
13-34942938-AG-CC NBEA-related disorder Uncertain significance (Feb 15, 2024)3061173
13-34942939-G-C Inborn genetic diseases Uncertain significance (Mar 14, 2023)2496467
13-34942942-G-A Uncertain significance (Jul 22, 2019)1318524
13-34942942-G-C NBEA-related disorder Uncertain significance (Sep 29, 2023)2630674
13-34942956-A-C Likely benign (Nov 01, 2023)2672539

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NBEAprotein_codingprotein_codingENST00000400445 58730736
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.005.55e-201246150111246260.0000441
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense5.518751.47e+30.5950.000074619241
Missense in Polyphen194540.220.359117330
Synonymous0.3445055150.9810.00002645628
Loss of Function10.751420.03520.000007781798

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001920.000192
Ashkenazi Jewish0.000.00
East Asian0.0001160.0000556
Finnish0.000.00
European (Non-Finnish)0.00003810.0000354
Middle Eastern0.0001160.0000556
South Asian0.00003510.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binds to type II regulatory subunits of protein kinase A and anchors/targets them to the membrane. May anchor the kinase to cytoskeletal and/or organelle-associated proteins (By similarity). {ECO:0000250}.;

Intolerance Scores

loftool
0.362
rvis_EVS
-1.89
rvis_percentile_EVS
1.98

Haploinsufficiency Scores

pHI
0.506
hipred
Y
hipred_score
0.761
ghis
0.580

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.836

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Nbea
Phenotype
embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype;

Zebrafish Information Network

Gene name
nbeaa
Affected structure
Mauthner neuron
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
protein localization
Cellular component
trans-Golgi network;cytosol;plasma membrane;endomembrane system
Molecular function
protein kinase binding